Harel Insurance Backs Omnix Medical in $25 Million Series C Funding Round
Omnix Medical, a Jerusalem-based biopharmaceutical company developing novel anti-infective therapies, has successfully raised $25 million in a Series C funding round co-led by Harel Insurance & Finance and the European Innovation Council (EIC) Fund.